{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:13:10Z","timestamp":1790701990573,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,10]]},"DOI":"10.7759\/cureus.53951","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T06:54:47Z","timestamp":1707548087000},"source":"Crossref","is-referenced-by-count":6,"title":["The Effectiveness of Myo-Inositol in Women With Polycystic Ovary Syndrome: A Prospective Clinical Study"],"prefix":"10.7759","author":[{"given":"Minthami","family":"Sharon P","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellonie","family":"P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Manivannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Thangaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logeswari","family":"B M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein IF","year":"1935","unstructured":"Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935, 29:181-91. 10.1016\/S0002-9378(15)30642-6","journal-title":"Am J Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a019031","article-title":"Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy","volume":"11","author":"Homburg R","year":"1996","unstructured":"Homburg R. Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod. 1996, 11:29-39. 10.1093\/oxfordjournals.humrep.a019031","journal-title":"Hum Reprod"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.131162","article-title":"A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India","volume":"18","author":"Joshi B","year":"2014","unstructured":"Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 2014, 18:317-24. 10.4103\/2230-8210.131162","journal-title":"Indian J Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.104104","article-title":"Prevalence of polycystic ovary syndrome in young women from North India: a community-based study","volume":"16","author":"Gill H","year":"2012","unstructured":"Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: a community-based study. Indian J Endocrinol Metab. 2012, 16:S389-92. 10.4103\/2230-8210.104104","journal-title":"Indian J Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2011.03.002","article-title":"Prevalence of polycystic ovarian syndrome in Indian adolescents","volume":"24","author":"Nidhi R","year":"2011","unstructured":"Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011, 24:223-7. 10.1016\/j.jpag.2011.03.002","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz R","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, et al.. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009, 91:456-88. 10.1016\/j.fertnstert.2008.06.035","journal-title":"Fertil Steril"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran LJ","year":"2010","unstructured":"Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010, 16:347-63. 10.1093\/humupd\/dmq001","journal-title":"Hum Reprod Update"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(92)91779-a","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina E","year":"1992","unstructured":"Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?. Am J Obstet Gynecol. 1992, 167:1807-12. 10.1016\/0002-9378(92)91779-a","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif A","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997, 18:774-800. 10.1210\/edrv.18.6.0318","journal-title":"Endocr Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.8.5054","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro RS","year":"1998","unstructured":"Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998, 83:2694-8. 10.1210\/jcem.83.8.5054","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061848","article-title":"Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility","volume":"13","author":"Calcaterra V","year":"2021","unstructured":"Calcaterra V, Verduci E, Cena H, et al.. Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility. Nutrients. 2021, 13:1848. 10.3390\/nu13061848","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","volume":"95","author":"Croze ML","year":"2013","unstructured":"Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013, 95:1811-27. 10.1016\/j.biochi.2013.05.011","journal-title":"Biochimie"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)40196-8","article-title":"Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid","volume":"265","author":"Oishi K","year":"1990","unstructured":"Oishi K, Zheng B, Kuo JF. Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid. J Biol Chem. 1990, 265:70-5. 10.1016\/S0021-9258(19)40196-8","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(90)90145-3","article-title":"Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells","volume":"39","author":"Haneda M","year":"1990","unstructured":"Haneda M, Kikkawa R, Arimura T, et al.. Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. Metabolism. 1990, 39:40-5. 10.1016\/0026-0495(90)90145-3","journal-title":"Metabolism"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(90)90056-j","article-title":"Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells","volume":"1052","author":"Olgem\u00f6ller B","year":"1990","unstructured":"Olgem\u00f6ller B, Schwaabe S, Schleicher ED, Gerbitz KD. Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells. Biochim Biophys Acta. 1990, 1052:47-52. 10.1016\/0167-4889(90)90056-j","journal-title":"Biochim Biophys Acta"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(89)90174-1","article-title":"The effect of elevated glucose levels on myo-inositol metabolism in cultured bovine aortic endothelial cells","volume":"38","author":"Yorek MA","year":"1989","unstructured":"Yorek MA, Dunlap JA. The effect of elevated glucose levels on myo-inositol metabolism in cultured bovine aortic endothelial cells. Metabolism. 1989, 38:16-22. 10.1016\/0026-0495(89)90174-1","journal-title":"Metabolism"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00313-3","article-title":"Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls","volume":"293","author":"Sun TH","year":"2002","unstructured":"Sun TH, Heimark DB, Nguygen T, Nadler JL, Larner J. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem Biophys Res Commun. 2002, 293:1092-8. 10.1016\/S0006-291X(02)00313-3","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(67)90357-8","article-title":"Metabolism of myo-inositol in animals. II. Complete catabolism of myo-inositol-14C by rat kidney slices","volume":"118","author":"Howard CF Jr","year":"1967","unstructured":"Howard CF Jr, Anderson L. Metabolism of myo-inositol in animals. II. Complete catabolism of myo-inositol-14C by rat kidney slices. Arch Biochem Biophys. 1967, 118:332-9. 10.1016\/0003-9861(67)90357-8","journal-title":"Arch Biochem Biophys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102314","article-title":"Health-promoting properties of selected cyclitols for metabolic syndrome and diabetes","volume":"11","author":"Antonowski T","year":"2019","unstructured":"Antonowski T, Osowski A, Lahuta L, G\u00f3recki R, Rynkiewicz A, Wojtkiewicz J. Health-promoting properties of selected cyclitols for metabolic syndrome and diabetes. Nutrients. 2019, 11:10.3390\/nu11102314","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.02.06.dc05-1070","article-title":"Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome","volume":"29","author":"Baillargeon JP","year":"2006","unstructured":"Baillargeon JP, Diamanti-Kandarakis E, Ostlund RE Jr, Apridonidze T, Iuorno MJ, Nestler JE. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care. 2006, 29:300-5. 10.2337\/diacare.29.02.06.dc05-1070","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81.19-25. 10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5455\/2320-1770.ijrcog20150234","article-title":"A comparative study of metabolic and hormonal effects of myoinositol vs. metformin in women with polycystic ovary syndrome: a randomised controlled trial","volume":"4","author":"Angik R","year":"2015","unstructured":"Angik R, Jajoo SS, Hariharan C, Chimote A. A comparative study of metabolic and hormonal effects of myoinositol vs. metformin in women with polycystic ovary syndrome: a randomised controlled trial. Int J Reprod Contracept Obstet Gynecol. 2015, 4:189-94. 10.5455\/2320-1770.ijrcog20150234","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4172\/2167-0943.1000127","article-title":"A combined treatment with myo-inositol and monacolin K improve the androgen and lipid profiles of insulin-resistant PCOS patients","volume":"2","author":"Leo VD","year":"2013","unstructured":"Leo VD, Musacchio MC, Cappelli V, et al.. A combined treatment with myo-inositol and monacolin K improve the androgen and lipid profiles of insulin-resistant PCOS patients. J Metab Synd. 2013, 2:127. 10.4172\/2167-0943.1000127","journal-title":"J Metab Synd"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.35460\/2546-1621.2021-0141","article-title":"Efficacy of myo-inositol in improving pregnancy rate and regulation of menstrual cycle for patients with polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"6","author":"Sigue RJL Decena DD","year":"2022","unstructured":"Sigue RJL Decena DD. Efficacy of myo-inositol in improving pregnancy rate and regulation of menstrual cycle for patients with polycystic ovarian syndrome: a systematic review and meta-analysis. J Med. 2022, 6:979-98. 10.35460\/2546-1621.2021-0141","journal-title":"J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1442-y","article-title":"Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"59","author":"Zeng L","year":"2018","unstructured":"Zeng L, Yang K. Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2018, 59:30-8. 10.1007\/s12020-017-1442-y","journal-title":"Endocrine"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-021-01073-3","article-title":"Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies","volume":"18","author":"Merviel P","year":"2021","unstructured":"Merviel P, James P, Bou\u00e9e S, Le Guillou M, Rince C, Nachtergaele C, Kerlan V. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reprod Health. 2021, 18:13. 10.1186\/s12978-021-01073-3","journal-title":"Reprod Health"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.743020","article-title":"Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study","volume":"29","author":"Artini PG","year":"2013","unstructured":"Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. Gynecol Endocrinol. 2013, 29:375-9. 10.3109\/09513590.2012.743020","journal-title":"Gynecol Endocrinol"},{"key":"ref28","article-title":"Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial","volume":"13","author":"Costantino D","year":"2009","unstructured":"Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci. 2009, 13:105-10.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/09513590801893232","article-title":"Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome","volume":"24","author":"Genazzani AD","year":"2008","unstructured":"Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008, 24:139-44. 10.1080\/09513590801893232","journal-title":"Gynecol Endocrinol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3206872","article-title":"Different effects of myoinositol plus folic acid versus combined oral treatment on androgen levels in PCOS women","volume":"2016","author":"Ozay AC","year":"2016","unstructured":"Ozay AC, Emekci Ozay O, Okyay RE, Cagliyan E, Kume T, Gulekli B. Different effects of myoinositol plus folic acid versus combined oral treatment on androgen levels in PCOS women. Int J Endocrinol. 2016, 2016:3206872. 10.1155\/2016\/3206872","journal-title":"Int J Endocrinol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23533","article-title":"Inositol, neural tube closure and the prevention of neural tube defects","volume":"109","author":"Greene ND","year":"2017","unstructured":"Greene ND, Leung KY, Copp AJ. Inositol, neural tube closure and the prevention of neural tube defects. Birth Defects Res. 2017, 109:68-80. 10.1002\/bdra.23533","journal-title":"Birth Defects Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-5005-0","article-title":"Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"299","author":"Vitagliano A","year":"2019","unstructured":"Vitagliano A, Saccone G, Cosmi E, Visentin S, Dessole F, Ambrosini G, Berghella V. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Arch Gynecol Obstet. 2019, 299:55-68. 10.1007\/s00404-018-5005-0","journal-title":"Arch Gynecol Obstet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/229112-the-effectiveness-of-myo-inositol-in-women-with-polycystic-ovary-syndrome-a-prospective-clinical-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T06:54:50Z","timestamp":1707548090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/229112-the-effectiveness-of-myo-inositol-in-women-with-polycystic-ovary-syndrome-a-prospective-clinical-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.53951","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,10]]}}}